Maybe you should take a wider perspective, this COVID-19 event began late last year. Picked up early this year, but in the preceding decade Mesoblast has been fairly assiduously working on solutions to other problems, one of those steroid refractory pediatric aGVHD. That particular indication is why there is manufacturing capability that is or has been assessed in the current BLA, don't know precisely when manufacturing sites, processes etc are inspected during a BLA. The other side is that indication is about ready to roll out, even before that a KOL outside of Mesoblast is wanting to investigate expanding the application to adults. There are quite a number of potential inflammatory conditions on the list of investigations to be done, some have progressed to P2 or even a little beyond.
Then there is the P3 CHF trial reading out in the next 2 or maybe 3 months, etc etc. Oh, and then there is Influenza and, in addition, other non-viral causes of ARDS, extensions.
Sure ARDS use would give Mesoblast a really good fillip if successful and used, and on the other side take away the fear of death to a significant extent in countries where similar solutions will become available. If they only fill that role for 6 months fine, Mesoblast will be nicely on its' way sooner rather than later this year.
I expect the questions will be resolved within the coming couple of months.
Again, Mesoblast was quite busy prosecuting the existing business plan when this came up.
- Forums
- ASX - By Stock
- MSB
- You wanna play with FIRE?
You wanna play with FIRE?, page-47
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
97.0¢ | $1.01 | 96.5¢ | $7.757M | 7.884M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 274918 | 97.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 974 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 103162 | 0.970 |
5 | 34741 | 0.965 |
11 | 125566 | 0.960 |
1 | 500 | 0.955 |
22 | 165429 | 0.950 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 974 | 1 |
0.990 | 10204 | 1 |
1.000 | 14000 | 1 |
1.010 | 2877 | 1 |
1.015 | 60000 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |